Hybrid cell lines were prepared by the fusion of mouse myeloma cells with the spleen cells of Wistar-Furth rats that had been immunized with a Moloney sarcoma virus (MoMuSV)-induced tumour, MFU. Two immunization protocols were designed. In the first, the animals received several injections of irradiated (10 000 rad) cells of a tumour cell line established in vitro, MFU-67. The rats received a booster injection 3 days prior to fusion. In the second protocol, immunization was the result of simple tumour growth, and no booster was given. Hybrids were tested by immunofluorescence for the production of immunoglobulins reacting with mouse cells acutely infected with MoMuSV. Over 20 ~ of reactive hybrids were observed in the tumour growth protocol, and about 10 ~o in the irradiated cell protocol when the last injection of the series was given 2 weeks before fusion. After 6 months, the proportion fell to 3~. Hybrid lines producing antibody to p30, the major core polypeptide of murine retroviruses, were obtained by cloning. Three of these were selected for closer study and were found to recognize three non-overlapping epitopes on p30. By direct and competitive binding in ELISA tests, the three epitopes were found to have very different distribution patterns among the various strains and isolates of murine retroviruses.
INTRODUCTION
The RNA of non-defective murine retroviruses consists of three viral genes, arranged in the order 5'~ag po~env-3', whose expression is required for translation. An initiation site near the 5' end allows translation of the gag gene resulting in the synthesis of a proximal precursor protein (Pr65~°g), which upon post-translational cleavage gives rise to the structural proteins of the virion core, p30 the major component, p 15, p 12 and p 10 (Van Zaane et al., 1975 ; Jamjoom et al., 1977) . The arrangement of the final virion proteins in Pr65 q°~ has ben established as N-p15-ppl2-p30-pl0 C (Oroszlan & Gilden, 1980) . The genome of Moloney murine sarcoma virus (Mo-MuSV), a replication-defective, sarcoma-inducing virus, consists of the complete gag gene at its 5' end; but lacks almost all of the pol and env genes, with variations in the deletion site among the various isolates (Fischinger, 1980; Van Beveren et al., 1981 ; Ball et al., 1973; Reddy et aL, 1980) . Antibodies to the structural components of the virion have been obtained by immunization of goats and rabbits with purified proteins. In view of the generally poor responsiveness of mice to p30, monoclonal antibodies to the virion envelope proteins, pl5(E) and gp70, but not to p30, have been obtained through immunization of mice with disrupted virions (Nowinski et al., 1979; Lostrom et al., 1979) . In contrast, rats bearing Mo-MuSV tumours readily produce antibodies to p30 (Hartley et al., 1965; Chuat et aL, 1971) .
In this study, we used a rhabdomyosarcoma (MFU) induced in a Wistar-Furth inbred rat by inoculation of the original Mo-MuSV isolate, and subsequently maintained by serial transplantation under syngeneic conditions (Guilhot & Chuat, 1983) , to obtain monoclonal antibodies to p30. METHODS 
Cells and viruses.
The origin of most of the retrovirus strains utilized in this study has been previously described (Chuat et al., 1971 (Chuat et al., , 1975 (Chuat et al., , 1978 Guilhot & Chuat, 1983) . Samples were obtained from cell lines maintained in this laboratory, or received as virus suspensions from colleagues or from the Viral Resources Laboratory (Frederick Cancer Research Center, Frederick, Md., U.S.A.). These included one or several lots of each of the major exogenous and endogenous strains: Moloney (Mo), Friend (F), Rauscher (R), Gross (G), Graffi (Gi), BALB-virus 1, BALB-virus 2, NZB-MuLV, NIH-MuLV, and AKR. In addition, we used Mo from line G8-124 (Ball et al., 1973) , human-grown Mo from line HU-124 (Devaux et al., 1980) , Rad-MuLV received from B. Guillemain, Ki-MSV/MuLV harvested from the Ki-NRK cell line provided by V. Klement, and cloned Ki-MuLV received from S. A. Aaronson and replicated in mouse cells. The methods employed for virus purification (sucrose gradients), viral protein extraction (Tween-ether) and p30 separation (Sephadex G-100) have also been reported. Cell line MFU (Guilhot & Chuat, 1983) was employed in one of the immunization procedures (see below). BALB/c mouse embryo cells (line 8828 from Dr Freeman, Microbiological Associates, Walkersville, Md., U.S.A.; 1968) were infected with Mo from line G8-124 by preincubating the cells for 4 h with growth medium containing 10 ~tg/ml Polybrene, followed by 2 h incubation with filtered G8-124 medium containing 10 gg/ml Polybrene. These cells were used in immunofluorescence and immunoprecipitation tests (see below).
Immunization, cell fusion, cloning and production of" monoclonal antibodies. Two procedures were used for immunization. In the first, immunization simply resulted from the rats carrying MFU tumour transplants. In the other procedure, MFU cells grown in vitro were washed in phosphate-buffered saline (PBS), irradiated (10000 rad) to prevent further multiplication and inoculated subcutaneously or intraperitoneally at 10-day intervals. The number of cells was increased at each of the eight inoculations performed, to reach a total of 1.6 x 108 cells, with a booster of non-irradiated cells 3 days before fusion. Spleen cells were fused with SP2/O-Ag-14 non-secretor myeloma cells (Shulman et al., 1978) in the presence of polyethylene glycol (PEG-4000, Serva) for 1.5 min and gently suspended in RPMI1640 (Gibco) containing 50 gM-hypoxanthine, 10 gM-azaserine, 2 mM-glutamine, 20 mM-glucose, 1 mM-sodium pyruvate, antibiotics and 20~ foetal bovine serum from which complement had been inactivated (HA medium). The cell suspension was then distributed into 24-well plates (106 cells/well in 1.5 ml). The medium was changed on days 7 (HA medium) and 11 (HA medium without azaserine). The presence of antibody was monitored in immunofluorescence tests, as described below, when the cell density averaged 30 to 50~ of the well surface. Hybridomas producing reactive antibody were cloned by limiting dilution in 96-well plates (0.5 cells/well in 0-2 ml) over a layer of irradiated (5000 rad) mink cells of line CCL64 (American Type Culture Collection). Positive clones were cloned again in order to select stable hybridomas.
Purification ofmonoclonal antibodies. Monoclonal antibodies were purified either from the growth medium of cell cultures or from ascites fluid harvested from nude mice inoculated intraperitoneally with about 0.5 x 106 to 1 x 106 cloned cells. Immunoglobulin was precipitated by addition of saturated (NH4)2SO ~ solution to a final concentration of 50 ~. In view of the lack of Protein A sites on the most frequent subclasses of rat I gG (Medgyesi et al., 1978) , purification based on their presence was not routinely attempted. The immunoglobulin concentration was adjusted to about 1 mg/ml by ultrafiltration (Cx30, Millipore).
Immunofluorescence (IF) tests. Antigens for IF tests were prepared as follows. Cells of line 8828 were grown in 96-well plates, infected with growth fluid from G8-124, as described above, and observed until the appearance of cytopathic changes. The cultures were then allowed to dry, fixed in cold ethanol for 10 min and stored at -20 °C until use. Dilutions of reference immune sera (from tumour-bearing animals) were used to calibrate each IF antigen. The antigen was incubated with the growth fluids to be tested (at 37 °C for 1 h followed by overnight incubation at 4 °C), washed and reacted with fluorescein-labelled goat IgG to rat IgG (Nordic Immunological Laboratories). The readings of the coded preparations were performed by two observers.
Determination of immunoglobulin isotypes. The isotypes were determined by double diffusion in agar against specific antisera (Nordic).
Radioimmunoassay (RIA) and competitive binding. Purified Mo p30 from 78A1 was labelled with 1251 (Amersham) using Iodogen (Fraker & Speck, 1978) . The ~zsI-p30 (about 30000 c.p.m.) was incubated with dilutions of the antibody to be studied (37 °C for 2 h and 4 °C overnight). The immunocomplexes were precipitated by incubation (37 °C for 1 h followed by 4 °C for 2 h) with goat anti-rat IgG (Cappel Laboratories) which had previously been attached to the Protein A of fixed Staphylococcus aureus (Cowan I strain) (37 °C for 1 h). For competitive binding assays, a dilution of the monoclonal antibody giving about 60 to 70~ of the plateau precipitation was incubated for 2 h at 37 °C with unlabelled antigen preparations prior to addition of 30000 c.p.m. of 125I_p30.
Enzyme-linked immunosorbent assay (ELISA). Monoclonal antibody (1 mg/ml) was conjugated with alkaline phosphatase (Sigma; 1.5 mg per 1 mg of antibody) by addition of glutaraldehyde to 0.06~. After dialysis against PBS, bovine serum albumin (BSA) was added to I ~. The wells of 96-well plates were coated by incubation with appropriate dilutions of p30 in 50 mM-carbonate buffer pH 9.6. After washing, binding sites on the plastic were saturated by incubation with 1 ~ BSA for 1 h at 37 °C, followed by rinsing with PBS pH 7.3, containing 0.05~ Tween 20 (PBS-T). Coated p30 was incubated at 37 °C for 2 h with suitable dilutions of monoclonal antibody conjugate (a suitable dilution was that giving about 1 absorbance unit in about 1 h). The bound alkaline phosphate conjugate was detected by adding the substrate p-nitrophenyl phosphate at 1 mg/ml in 100 mM-diethanolamine buffer pH 9.8. After hydrolysis, absorbance at 405 nm was measured using a Dynatech MR 580 photometer.
Immunopreeipitation (IP) and polyacrylamide gel analysis of labelled proteins. Labelling of cells with
[35S]methionine, 14C-amino acid mixture, [3H]valine and [3H]leucine, immunoprecipitation, PAGE and photofluorography were carried out as described previously (Guilhot & Chuat, 1983) . Ceils of line 8828 were labelled 45 h after infection with Mo-MuSV-124 and lysed at 48 h.
RESULTS
Hybridoma cell lines producing anti-p30 antibodies were obtained by fusion of SP2/O-Ag-14 mouse myeloma cells with lymphocytes from the spleens of Wistar-Furth rats immunized by the procedures described in Methods. About 10 days after fusion no. 9, performed following immunization with irradiated MFU cells, growth of hybrid cells was observed in 67 ~o (170/252) of the wells. Growth medium from these wells was assayed in IF tests for the presence of antibody, using Mo-MuSV-124-infected mouse fibroblasts. About 3 ~ (6/170) of the hybridomas proved positive, and cloned hybridoma 9B 18 was selected for its stability and its high anti-p30 reactivity in immunoprecipitation tests. In fusion no. 13, where immunization resulted from simple tumour growth, hybrids were also scored in 10 days in 67~ (227/336) of the wells but, surprisingly, 23~ (54/227) were found positive in IF tests. Of the 54 hybridomas, 14 gave stable clones of which two (13ED 2a4 and 13NA 2c) were selected for further study.
Monoclonal antibody secreted by 9B 18 and 13ED 2a4 was found to belong to the IgG2a subclass, which does not bind staphylococcal Protein A (SPA) (Medgyesi et al., 1978) . The IgG from 13NA 2c was of the IgG1 subclass, and thus did bind SpA. However, goat anti-rat IgG was included in all the tests involving a SpA-mediated precipitation step.
Identification of the prom& recognized
Culture supernatants and/or ascites fluids were tested for their ability to precipitate p30 both in purified virus and in virus-infected cells. The results shown in Fig. 1, involving 9B 18 , indicate that the antibody produced by this clone recognizes the p30 polypeptide in Moloney and Gross virions, and in Mo-MuSV-infected cells. In short-term labelling of 78A1 cells, the 9B 18 antibody detected both p30 and the Pr65g~ precursor polypeptide (Fig. 1, lane 8) . The observation that Friend virus p30 lacks this epitope (Fig. 1, lane 5 ) is in keeping with the results of the ELISA tests to be described below.
Evidence for non-overlapping epitopes on Moloney virus p30
As expected, the IF and IP tests showed that all three clones recognized Moloney virus p30. Accordingly, this polypeptide was chosen to determine whether the epitopes recognized by the three monoclonal antibodies were overlapping or adjacent on the molecule. The ELISA technique was employed. Various amounts of unconjugated antibody were incubated at 37 °C for 2 h in wells coated with 1.2 ~tg of Moloney virus p30. After washing, the wells were reacted with an appropriate dilution of enzyme-conjugated antibody. The data of Fig. 2 indicate that only self-competition was observed, and therefore that the epitopes do not overlap and are not closely adjacent on the Moloney virus p30.
Presence of the epitope recognized by 9B 18 antibody on all Motoney virus isolates
RIA was chosen initially to determine by competitive binding the distribution of the three epitopes recognized by 9B 18, 13ED 2a4 and 13NA 2c among the major murine retrovirus strains. For this, antigen preparations consisting of virus suspensions, Tween ether-extracted proteins and purified p30 polypeptides from the major murine retrovirus isolates, and from controls, were incubated for 2 h at 37 °C with an antibody dilution that gave 60~ precipitation, prior to addition of ~ 25I-labelled Moloney virus p30. The most clear-cut competition curves were obtained with 9B 18 antibody, and it appeared that competitiveness was restricted to Moloney virus preparations, all the others being totally ineffective. For the sake of clarity, the competition curves obtained with four antigens only are plotted in Fig. 3 . However, closely similar curves, with almost parallel slopes, were obtained with 19 Moloney virus preparations from different laboratories, including specimens of the standard, and the Mo-MuSV-124 and HU-124 isolates. The degree of purity of the preparation (virus suspension, protein extract or purified p30) had no bearing on the slope of the curve, provided that comparable amounts of p30, as estimated in the preparations, were utilized.
Distribution of the epitopes recognized among the major murine retrovirus strains
Since RIA was not readily amenable to the study of the distribution of the three epitopes outside of the Moloney virus strains, we resorted to ELISA. In the direct assay, p30 or p30-containing preparations were used for coating the wells as described in Methods. We thus confirmed that the 9B 18 epitope was not present on Friend virus p30. In an attempt to define the epitope distribution among the major murine retrovirus strains, we found that inhibition of binding to Moloney virus p30 appeared to give the most reproducible results. The curves obtained with the three monoclonal antibodies in one series of experiments are given in Fig. 4 .
DISCUSSION
We describe here the isolation and characterization of monoclonal antibodies specific for the p30 core polypeptide of murine retroviruses. The monoclonal antibodies were derived after immunization of rats. This confirmed the prediction that rats would readily produce monoclonal antibodies to p30, whereas mice would do so very poorly, if at all (Lostrom et aL, 1979) . In fact, the few monoclonal antibodies to p30 reported recently were all obtained in rats (Chesebro et a[., 1983; Gambke et al., 1984) .
In the present studies, the animals were immunized with tumour cells containing an MoMuSV genome, probably very closely related to type ml (Guilhot & Chuat, 1983) . Fusion of rat spleen cells with a mouse myeloma did not raise more problems than the mouse × mouse fusions (not reported here) which we performed concomitantly. The overall results of fusions 9 and 13, from which the hybridomas reported here were derived, suggest that immunization through the presence of a tumour is a more effective stimulus than repeated injection of irradiated cells from the tumour cell line grown in vitro. In fact, the clearly better results of the former procedure over the latter (23 ~o compared to 3 ~) is all the more convincing in view of the equivalent percentage of hybridoma growth (67~). However, in fusion no. 9, about 6 months had elapsed between the last of the series of injections, and the booster. In fusion no. 7 (which gave rise to hybridomas not described here), the booster was given 2 weeks after a series of three injections, and its results were better than those of fusion no. 9 (337/384 wells with hybrids, i.e. 88 ~, and 38/337, i.e. 11 ~, positive). Thus, the difference between the results of the two immunization methods employed in the present study might lie in the major type of antibody-producing cell available at the time of fusion. Since both procedures appeared to give satisfactory results, the advantage of using irradiated cells is that they can be freely adapted to any protocol, and eventually to hyperimmunization, whereas immunization through tumour bearing must necessarily be of comparatively shorter duration.
The three cloned hybridomas that were submitted to more complete study were selected on the basis of their reactivity to p30, their stability, the availability of sufficiently concentrated growth fluid and/or ascites samples and above all their ability to detect different epitopes on p30. A number of the other hybridomas obtained following immunization of rats with the M FU tumour or with MFU-67 cells were also directed against p30, but were not studied further. Still others were not found to react with Mo p30 in IP tests, whether for lack of reactivity or for some other reason such as insufficient concentration at the time of assay. In view of the relatively large number of hybridomas found positive in IF tests, complete characterization of all the hybrids would have required an excessive amount of the various (non-commercial) reagents utilized.
Three epitopes could be defined by reciprocal competitive binding in ELISA. The results of the RIA competitions showed that the 9B 18 epitope was present on all the Moloney virus isolates and samples examined. The affinity of 9B 18 for its epitope seems to be very high, although we did not measure it. This high affinity probably accounts for the lack of competitive ability in RIA exhibited by various preparations of Gross virus, a finding at variance with the evidence from IP analysis and SDS-PAGE, that Gross p30 could be readily recognized by 9B 18. Competition.in ELISA showed that a crossreacting epitope was indeed present on Gross virus p30. On the other hand, the lack of such a crossreaction with Friend virus p30 was confirmed by both competition and direct ELISA.
The other two hybridomas, 13ED 2a4 and 13NA 2c, also gave the strongest reaction with Moloney virus in direct and competitive ELISA. However, their epitopes are different, as shown not only by the absence of steric hindrance in tests where unlabelled antibody from one of the hybridomas was used as a competitor against a conjugate of the other, but also by the different distribution of the epitopes among the major strains of murine retroviruses. For instance, the 13ED 2a4 site, in addition to being recognized in the Moloney strains, was detected easily on p30 from the endogenous strain BALB-virus 2, whereas in the case of 13NA 2c, the apparently corresponding epitope density is observed on Graffi virus p30. The distinction was made even clearer when the 13ED 2a4 antibody was found not to react at all with Graffi virus p30. It may be added that the affinity of the two hybridomas from fusion no. 13 for their respective epitope is clearly less than that of 9B 18. Here again, this might reflect the difference in the immunization protocols, as the selection of the splenocytes occurred at an earlier stage of the immunological response.
Type-specific antigenic determinants, as detected by immune sera, have been described by several authors on the p30 polypeptide (Strand & August, 1974; Stephenson et al., 1974) , as well as interstrain biophysical and amino acid sequence differences (Oroszlan et al., 1974; Chuat et al., 1975 Chuat et al., , 1978 . The present studies confirm the existence of such interstrain differences by using monoclonal antibodies, and may provide new tools for their localization on the molecule.
